TheProfitWatch

PALI - Palisade Bio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.36 -0.21 (-9.11%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (-0.23%) 0.0 (0.0%) -0.19 (-8.33%) -0.1 (-4.26%) 0.02 (0.85%)

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.58
Diluted EPS:
-0.58
Basic P/E:
-3.6983
Diluted P/E:
-3.6983
RSI(14) 1m:
50.0
VWAP:
2.15
RVol:

Events

Period Kind Movement Occurred At

Related News